Incidence and cost of anal, penile, vaginal and vulvar cancer in Denmark

BMC Public Health

Table 2 Mean annual hospital cost (2008 prices) per patient of anal, penile, vaginal and vulvar cancer

	Year before diagnosis*, €	1^styear**, €	2^ndyear**, €	3^rdyear**, €
	(95% CI)	(95% CI)	(95% CI)	(95% CI)
Anal cancer	4,285	23,557	7,926	5,753
Anal cancer	(3,260-5,612)	(18,298-30,323)	(6,119-10,265)	(4,266-7,750)
Anal cancer, men	4,524	25,335	8,567	6,498
Anal cancer, men	(2,953-6,931)	(16,248-39,420)	(5,715-12,818)	(3,921-10,736)
Anal cancer, women	4,143	22,620	7,608	5,440
Anal cancer, women	(2,991-5,735)	(16,475-31,038)	(5,585-10,364)	(3,901-7,586)
Penile cancer	2,238	12,497	3,968	3,634
Penile cancer	(1,758-2,644)	(9,146-17,075)	(3,034-5,149)	(2,458-5,290)
Vaginal cancer	3,789	17,154	7,215	***
Vaginal cancer	(2,394-5,986)	(9,794-29,925)	(4,189-12,425)	***
Vulvar cancer	2,824	12,353	4,044	4,269
Vulvar cancer	(2,271-3,477)	(9,382-16,260)	(3,132-5,211)	(3,034-5,995)

* The average cost 0–12 months before the date of diagnosis.
** The average cost 0–12 months after the date of diagnosis, 13–24 months after the date of diagnosis for living patients, and 25–36 months after the date of diagnosis for living patients.
*** Results not estimated due to few observations.
€ 1.00 = DKK 7.45.

ISSN: 1471-2458